Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,002 | -84,234 | -68,406 | -61,169 | -48,159 |
| Depreciation Amortization | 1,085 | 5,601 | 4,498 | 3,395 | 2,065 |
| Accounts receivable | N/A | N/A | -7,000 | N/A | N/A |
| Other Working Capital | -743 | 1,634 | -7,675 | -1,778 | -2,265 |
| Other Operating Activity | 2,075 | 41,980 | 45,174 | 36,845 | 35,127 |
| Operating Cash Flow | $-13,585 | $-35,019 | $-33,409 | $-22,707 | $-13,232 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,820 | -82,378 | -88,193 | -93,048 | -75,392 |
| PPE Investments | -444 | -1,336 | -1,303 | -1,032 | -479 |
| Investing Cash Flow | $9,376 | $-83,714 | $-89,496 | $-94,080 | $-75,871 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,758 | 1,758 | 1,758 | N/A |
| Common Stock Issued | 5,878 | 178 | 175 | 175 | N/A |
| Financing Cash Flow | $5,878 | $1,936 | $1,933 | $1,933 | $N/A |
| Beginning Cash Position | 13,571 | 130,368 | 130,368 | 130,368 | 130,368 |
| End Cash Position | 15,240 | 13,571 | 9,396 | 15,514 | 41,265 |
| Net Cash Flow | $1,669 | $-116,797 | $-120,972 | $-114,854 | $-89,103 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,585 | -35,019 | -33,409 | -22,707 | -13,232 |
| Capital Expenditure | -444 | -1,336 | -1,303 | -1,032 | -479 |
| Free Cash Flow | -14,029 | -36,355 | -34,712 | -23,739 | -13,711 |